1h Free Analyst Time
The microarray biochips market is forecasted to grow by USD 17.27 billion during 2023-2028, accelerating at a CAGR of 22.2% during the forecast period. The report on the microarray biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in market presence with collaboration strategy, growing use of personalized medicines, and rising demand for microarray biochips in genomics and proteomics.
The microarray biochips market is segmented as below:
By Application
- Drug discovery and development
- Diagnostics and treatments
- Research and consumables
- Forensic medicines
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the microarray biochips market covers the following areas:
- Microarray Biochips Market sizing
- Microarray Biochips Market forecast
- Microarray Biochips Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global microarray biochips market: Agilent Technologies Inc., Applied Microarrays Inc., Arrayit Corp., BioChain Institute Inc., Bio Rad Laboratories Inc., BioIVT LLC, Biometrix Technology Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Fluidigm Corp., General Electric Co., Illumina Inc., Merck KGaA, Pantomics Inc., Perkin Elmer Inc., Protein Biotechnologies Inc., RayBiotech Life Inc., Sengenics Corp. LLC, Super BioChips Laboratories, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emerging loc technology."
According to the report, one of the major drivers for this market is the increase in market presence with collaboration strategy.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Applied Microarrays Inc.
- Arrayit Corp.
- BioChain Institute Inc.
- Bio Rad Laboratories Inc.
- BioIVT LLC
- Biometrix Technology Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Fluidigm Corp.
- General Electric Co.
- Illumina Inc.
- Merck KGaA
- Pantomics Inc.
- Perkin Elmer Inc.
- Protein Biotechnologies Inc.
- RayBiotech Life Inc.
- Sengenics Corp. LLC
- Super BioChips Laboratories
- Thermo Fisher Scientific Inc.
